Published in Biotechnol Lett on January 01, 2003
Intratumoral immunocytokine treatment results in enhanced antitumor effects. Cancer Immunol Immunother (2008) 1.13
Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice. Cancer Immunol Immunother (2011) 0.95
Effective melanoma immunotherapy in mice by the skin-depigmenting agent monobenzone and the adjuvants imiquimod and CpG. PLoS One (2010) 0.88
Electrotransfer of single-stranded or double-stranded DNA induces complete regression of palpable B16.F10 mouse melanomas. Cancer Gene Ther (2013) 0.84
CpG oligodeoxynucleotides inhibit tumor growth and reverse the immunosuppression caused by the therapy with 5-fluorouracil in murine hepatoma. World J Gastroenterol (2005) 0.82
Co-administration of a DNA vaccine encoding the prostate specific membrane antigen and CpG oligodeoxynucleotides suppresses tumor growth. J Transl Med (2004) 0.78
Cytokines and chemokines are expressed at different levels in small and large murine colon-26 tumors following intratumoral injections of CpG ODN. Neoplasia (2004) 0.78
Immunostimulatory and anti-neoplasm effects of a novel palindrome CpG oligodeoxynucleotide in mice. Acta Pharmacol Sin (2012) 0.76
Systemic delivery of chTNT-3/CpG immunoconjugates for immunotherapy in murine solid tumor models. Cancer Immunol Immunother (2016) 0.75
Antitumor and Antimetastatic Effect of Small Immunostimulatory RNA against B16 Melanoma in Mice. PLoS One (2016) 0.75
Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med (2006) 15.64
Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med (2014) 10.69
Optimal reactive vaccination strategies for a foot-and-mouth outbreak in the UK. Nature (2006) 4.05
Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg (2005) 3.80
The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I). Ann Surg Oncol (2010) 3.02
Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I). Ann Surg Oncol (2012) 1.92
Retroperitoneal sarcomas: grade and survival. Arch Surg (2003) 1.54
Accuracy of models for the 2001 foot-and-mouth epidemic. Proc Biol Sci (2008) 1.52
Topographic determinants of foot and mouth disease transmission in the UK 2001 epidemic. BMC Vet Res (2006) 1.43
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. J Immunol (2008) 1.24
Using conservation of pattern to estimate spatial parameters from a single snapshot. Proc Natl Acad Sci U S A (2004) 1.10
IL-12 reverses anergy to T cell receptor triggering in human lung tumor-associated memory T cells. Clin Immunol (2005) 1.09
Effect of data quality on estimates of farm infectiousness trends in the UK 2001 foot-and-mouth disease epidemic. J R Soc Interface (2007) 0.96
Discharge independence with minimally invasive lobectomy. Am J Surg (2004) 0.91
Reciprocal functional modulation of the activation of T lymphocytes and fibroblasts derived from human solid tumors. J Immunol (2010) 0.89
Manual exfoliation plus immunomagnetic bead separation as an initial step toward translational research. Arch Pathol Lab Med (2006) 0.85
Resection of tumors of the ischiorectal fossa. J Am Coll Surg (2003) 0.85
Human CD4+ effector T cells mediate indirect interleukin-12- and interferon-gamma-dependent suppression of autologous HLA-negative lung tumor xenografts in severe combined immunodeficient mice. Cancer Res (2002) 0.83
Adoptively transferred human lung tumor specific cytotoxic T cells can control autologous tumor growth and shape tumor phenotype in a SCID mouse xenograft model. J Transl Med (2007) 0.82
Desmoplastic small round cell tumor of the pleura. Pediatr Blood Cancer (2007) 0.82
Surgical technique for totally implantable access ports (TIAP) needs improvement. J Surg Oncol (2007) 0.81
Technique of forequarter (interscapulothoracic) amputation. Clin Orthop Relat Res (2004) 0.81
Cytokines and chemokines are expressed at different levels in small and large murine colon-26 tumors following intratumoral injections of CpG ODN. Neoplasia (2004) 0.78
Cutdowns for totally implantable access ports to central veins. Vascular (2009) 0.77
Internal packing in the control of hemorrhage from large retroperitoneal veins. Am J Surg (2005) 0.77
Intratumoral injection of GM-CSF in perspective - a review. J Med (2003) 0.77
Human nasal polyp microenvironments maintained in a viable and functional state as xenografts in NOD-scid IL2rgamma(null) mice. Ann Otol Rhinol Laryngol (2009) 0.77
Surgical lymphedema and its assessment. J Surg Oncol (2007) 0.75
Quantitative aspects of the relationship between the tumor and host response. J Med (2003) 0.75
Large gaps of midline abdominal incisions and their management. Am Surg (2008) 0.75
Coordination in cancer research: Enough? J Surg Oncol (2009) 0.75
Identification of pathology from diesel exhaust particles in the bladder in a rat model by aspiration of particles from the pharynx. Environ Toxicol Pharmacol (2013) 0.75
Modified anterior compartment resection of the thigh. Int Surg (2008) 0.75
Flank incision for adenocarcinoma of the splenic flexure in the obese. J Surg Oncol (2003) 0.75
Is immunosuppression at the tumor site mechanism of evasion of a systemic response? J Med (2003) 0.75
Reducing toxicity of cisplatin in cancer chemotherapy by extracorporeal removal of excess cisplatin. J Med (2002) 0.75
Refinements of surgical technique in oncologic surgery. J Surg Oncol (2010) 0.75
Granulocyte-macrophage colony-stimulating factor (GM-CSF) restores allostimulatory function to accessory cells in patients with AIDS. HIV Clin Trials (2002) 0.75